45 pages, 3558 KiB  
Review
Sustainable Biodegradable Biopolymer-Based Nanoparticles for Healthcare Applications
by Nika Kučuk 1, Mateja Primožič 1, Željko Knez 1,2 and Maja Leitgeb 1,2,*
1 Faculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova Ulica 17, 2000 Maribor, Slovenia
2 Faculty of Medicine, University of Maribor, Taborska Ulica 8, 2000 Maribor, Slovenia
Int. J. Mol. Sci. 2023, 24(4), 3188; https://doi.org/10.3390/ijms24043188 - 6 Feb 2023
Cited by 80 | Viewed by 10595
Abstract
Biopolymeric nanoparticles are gaining importance as nanocarriers for various biomedical applications, enabling long-term and controlled release at the target site. Since they are promising delivery systems for various therapeutic agents and offer advantageous properties such as biodegradability, biocompatibility, non-toxicity, and stability compared to [...] Read more.
Biopolymeric nanoparticles are gaining importance as nanocarriers for various biomedical applications, enabling long-term and controlled release at the target site. Since they are promising delivery systems for various therapeutic agents and offer advantageous properties such as biodegradability, biocompatibility, non-toxicity, and stability compared to various toxic metal nanoparticles, we decided to provide an overview on this topic. Therefore, the review focuses on the use of biopolymeric nanoparticles of animal, plant, algal, fungal, and bacterial origin as a sustainable material for potential use as drug delivery systems. A particular focus is on the encapsulation of many different therapeutic agents categorized as bioactive compounds, drugs, antibiotics, and other antimicrobial agents, extracts, and essential oils into protein- and polysaccharide-based nanocarriers. These show promising benefits for human health, especially for successful antimicrobial and anticancer activity. The review article, divided into protein-based and polysaccharide-based biopolymeric nanoparticles and further according to the origin of the biopolymer, enables the reader to select the appropriate biopolymeric nanoparticles more easily for the incorporation of the desired component. The latest research results from the last five years in the field of the successful production of biopolymeric nanoparticles loaded with various therapeutic agents for healthcare applications are included in this review. Full article
(This article belongs to the Special Issue Functional Nanomaterials for Healthcare)
Show Figures

Figure 1

32 pages, 2260 KiB  
Review
MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism
by Yen My Vuu, Chris-Tiann Roberts and Mojgan Rastegar *
Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada
Int. J. Mol. Sci. 2023, 24(4), 4218; https://doi.org/10.3390/ijms24044218 - 20 Feb 2023
Cited by 24 | Viewed by 10422
Abstract
DNA methylation, one of the most well-studied epigenetic modifications, is involved in a wide spectrum of biological processes. Epigenetic mechanisms control cellular morphology and function. Such regulatory mechanisms involve histone modifications, chromatin remodeling, DNA methylation, non-coding regulatory RNA molecules, and RNA modifications. One [...] Read more.
DNA methylation, one of the most well-studied epigenetic modifications, is involved in a wide spectrum of biological processes. Epigenetic mechanisms control cellular morphology and function. Such regulatory mechanisms involve histone modifications, chromatin remodeling, DNA methylation, non-coding regulatory RNA molecules, and RNA modifications. One of the most well-studied epigenetic modifications is DNA methylation that plays key roles in development, health, and disease. Our brain is probably the most complex part of our body, with a high level of DNA methylation. A key protein that binds to different types of methylated DNA in the brain is the methyl-CpG binding protein 2 (MeCP2). MeCP2 acts in a dose-dependent manner and its abnormally high or low expression level, deregulation, and/or genetic mutations lead to neurodevelopmental disorders and aberrant brain function. Recently, some of MeCP2-associated neurodevelopmental disorders have emerged as neurometabolic disorders, suggesting a role for MeCP2 in brain metabolism. Of note, MECP2 loss-of-function mutation in Rett Syndrome is reported to cause impairment of glucose and cholesterol metabolism in human patients and/or mouse models of disease. The purpose of this review is to outline the metabolic abnormalities in MeCP2-associated neurodevelopmental disorders that currently have no available cure. We aim to provide an updated overview into the role of metabolic defects associated with MeCP2-mediated cellular function for consideration of future therapeutic strategies. Full article
(This article belongs to the Special Issue Molecular Insights in Psychiatry 2.0)
Show Figures

Graphical abstract

23 pages, 3211 KiB  
Review
Inhibition of Succinate Dehydrogenase by Pesticides (SDHIs) and Energy Metabolism
by Frederic Bouillaud
Institut Cochin, INSERM, CNRS, Université Paris Cité, 75014 Paris, France
Int. J. Mol. Sci. 2023, 24(4), 4045; https://doi.org/10.3390/ijms24044045 - 17 Feb 2023
Cited by 31 | Viewed by 10130
Abstract
Succinate dehydrogenase (SDH) is one of the enzymes of the tricarboxylic acid cycle (Krebs cycle) and complex II of the mitochondrial respiratory chain. A class of fungicides (SDHIs) targets the complex II reaction in the SDH. A large number of those in use [...] Read more.
Succinate dehydrogenase (SDH) is one of the enzymes of the tricarboxylic acid cycle (Krebs cycle) and complex II of the mitochondrial respiratory chain. A class of fungicides (SDHIs) targets the complex II reaction in the SDH. A large number of those in use have been shown to inhibit SDH in other phyla, including humans. This raises questions about possible effects on human health and non-target organisms in the environment. The present document will address metabolic consequences in mammals; it is neither a review on SDH nor is it about the toxicology of SDHIs. Most clinically relevant observations are linked to a severe decrease in SDH activity. Here we shall examine the mechanisms for compensating a loss of SDH activity and their possible weaknesses or adverse consequences. It can be expected that a mild inhibition of SDH will be compensated by the kinetic properties of this enzyme, but this implies a proportionate increase in succinate concentration. This would be relevant for succinate signaling and epigenetics (not reviewed here). With regard to metabolism, exposure of the liver to SDHIs would increase the risk for non-alcoholic fatty liver disease (NAFLD). Higher levels of inhibition may be compensated by modification of metabolic fluxes with net production of succinate. SDHIs are much more soluble in lipids than in water; consequently, a different diet composition between laboratory animals and humans is expected to influence their absorption. Full article
(This article belongs to the Special Issue 25th Anniversary of IJMS: Advances in Biochemistry)
Show Figures

Figure 1

21 pages, 9128 KiB  
Review
The Use of Collagen-Based Materials in Bone Tissue Engineering
by Lu Fan 1,2,†, Yanru Ren 3,†, Steffen Emmert 3, Ivica Vučković 4, Sanja Stojanovic 5,6, Stevo Najman 5,6, Reinhard Schnettler 7, Mike Barbeck 3,8, Katja Schenke-Layland 1,2,* and Xin Xiong 1,*
1 NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, 72770 Reutlingen, Germany
2 Institute of Biomedical Engineering, Department of Medical Technologies and Regenerative Medicine, Medical Faculty, Eberhard Karls University of Tübingen, Silcherstr. 7/1, 72076 Tübingen, Germany
3 Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Strempelstraße 13, 18057 Rostock, Germany
4 Department of Maxillofacial Surgery, Clinic for Dental Medicine, 18000 Niš, Serbia
5 Department for Cell and Tissue Engineering, Scientific Research Center for Biomedicine, Faculty of Medicine, University of Niš, 18000 Niš, Serbia
6 Department of Biology and Human Genetics, Faculty of Medicine, University of Niš, 18000 Niš, Serbia
7 University Medical Centre, Justus Liebig University of Giessen, 35390 Giessen, Germany
8 BerlinAnalytix GmbH, Ullsteinstraße 108, 12109 Berlin, Germany
These authors contributed equally to this work.
Int. J. Mol. Sci. 2023, 24(4), 3744; https://doi.org/10.3390/ijms24043744 - 13 Feb 2023
Cited by 76 | Viewed by 10008
Abstract
Synthetic bone substitute materials (BSMs) are becoming the general trend, replacing autologous grafting for bone tissue engineering (BTE) in orthopedic research and clinical practice. As the main component of bone matrix, collagen type I has played a critical role in the construction of [...] Read more.
Synthetic bone substitute materials (BSMs) are becoming the general trend, replacing autologous grafting for bone tissue engineering (BTE) in orthopedic research and clinical practice. As the main component of bone matrix, collagen type I has played a critical role in the construction of ideal synthetic BSMs for decades. Significant strides have been made in the field of collagen research, including the exploration of various collagen types, structures, and sources, the optimization of preparation techniques, modification technologies, and the manufacture of various collagen-based materials. However, the poor mechanical properties, fast degradation, and lack of osteoconductive activity of collagen-based materials caused inefficient bone replacement and limited their translation into clinical reality. In the area of BTE, so far, attempts have focused on the preparation of collagen-based biomimetic BSMs, along with other inorganic materials and bioactive substances. By reviewing the approved products on the market, this manuscript updates the latest applications of collagen-based materials in bone regeneration and highlights the potential for further development in the field of BTE over the next ten years. Full article
(This article belongs to the Special Issue Biomaterials for Bone Tissue Engineering 3.0)
Show Figures

Figure 1

24 pages, 2073 KiB  
Review
The Impact of Exercise on Immunity, Metabolism, and Atherosclerosis
by Ulrike Meyer-Lindemann 1,2, Aldo Moggio 1, Alexander Dutsch 1,2, Thorsten Kessler 1,2 and Hendrik B. Sager 1,2,*
1 Department of Cardiology, German Heart Center Munich, Technical University Munich, 80636 Munich, Germany
2 DZHK e.V. (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80336 Munich, Germany
Int. J. Mol. Sci. 2023, 24(4), 3394; https://doi.org/10.3390/ijms24043394 - 8 Feb 2023
Cited by 22 | Viewed by 9924
Abstract
Physical exercise represents an effective preventive and therapeutic strategy beneficially modifying the course of multiple diseases. The protective mechanisms of exercise are manifold; primarily, they are elicited by alterations in metabolic and inflammatory pathways. Exercise intensity and duration strongly influence the provoked response. [...] Read more.
Physical exercise represents an effective preventive and therapeutic strategy beneficially modifying the course of multiple diseases. The protective mechanisms of exercise are manifold; primarily, they are elicited by alterations in metabolic and inflammatory pathways. Exercise intensity and duration strongly influence the provoked response. This narrative review aims to provide comprehensive up-to-date insights into the beneficial effects of physical exercise by illustrating the impact of moderate and vigorous exercise on innate and adaptive immunity. Specifically, we describe qualitative and quantitative changes in different leukocyte subsets while distinguishing between acute and chronic exercise effects. Further, we elaborate on how exercise modifies the progression of atherosclerosis, the leading cause of death worldwide, representing a prime example of a disease triggered by metabolic and inflammatory pathways. Here, we describe how exercise counteracts causal contributors and thereby improves outcomes. In addition, we identify gaps that still need to be addressed in the future. Full article
(This article belongs to the Special Issue Effects of Exercise Release Mediated Myokines on Immune System)
Show Figures

Figure 1

28 pages, 2517 KiB  
Review
Recent Advances in Methods for Circulating Tumor Cell Detection
by Monika Vidlarova 1,2,†, Alona Rehulkova 1,2,†, Pavel Stejskal 1,2, Andrea Prokopova 1, Hanus Slavik 3, Marian Hajduch 1,2 and Josef Srovnal 1,2,*
1 Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, 779 00 Olomouc, Czech Republic
2 Laboratory of Experimental Medicine, University Hospital in Olomouc, 779 00 Olomouc, Czech Republic
3 Centre National de la Recherche Scientifique, Institut des Neurosciences Cellulaires et Intégratives, Université de Strasbourg, 67000 Strasbourg, France
These authors contributed equally to this work.
Int. J. Mol. Sci. 2023, 24(4), 3902; https://doi.org/10.3390/ijms24043902 - 15 Feb 2023
Cited by 46 | Viewed by 9848
Abstract
Circulating tumor cells (CTCs) are released from primary tumors and transported through the body via blood or lymphatic vessels before settling to form micrometastases under suitable conditions. Accordingly, several studies have identified CTCs as a negative prognostic factor for survival in many types [...] Read more.
Circulating tumor cells (CTCs) are released from primary tumors and transported through the body via blood or lymphatic vessels before settling to form micrometastases under suitable conditions. Accordingly, several studies have identified CTCs as a negative prognostic factor for survival in many types of cancer. CTCs also reflect the current heterogeneity and genetic and biological state of tumors; so, their study can provide valuable insights into tumor progression, cell senescence, and cancer dormancy. Diverse methods with differing specificity, utility, costs, and sensitivity have been developed for isolating and characterizing CTCs. Additionally, novel techniques with the potential to overcome the limitations of existing ones are being developed. This primary literature review describes the current and emerging methods for enriching, detecting, isolating, and characterizing CTCs. Full article
(This article belongs to the Special Issue Circulating Tumor Cells: From Research to Therapeutic Application)
Show Figures

Figure 1

22 pages, 1079 KiB  
Review
Microfluidic Organ-on-A-chip: A Guide to Biomaterial Choice and Fabrication
by Uyen M. N. Cao, Yuli Zhang, Julie Chen, Darren Sayson, Sangeeth Pillai and Simon D. Tran *
McGill Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dental Medicine and Oral Health Sciences, McGill University, 3640 University Street, Montreal, QC H3A 0C7, Canada
Int. J. Mol. Sci. 2023, 24(4), 3232; https://doi.org/10.3390/ijms24043232 - 6 Feb 2023
Cited by 80 | Viewed by 9743
Abstract
Organ-on-A-chip (OoAC) devices are miniaturized, functional, in vitro constructs that aim to recapitulate the in vivo physiology of an organ using different cell types and extracellular matrix, while maintaining the chemical and mechanical properties of the surrounding microenvironments. From an end-point perspective, the [...] Read more.
Organ-on-A-chip (OoAC) devices are miniaturized, functional, in vitro constructs that aim to recapitulate the in vivo physiology of an organ using different cell types and extracellular matrix, while maintaining the chemical and mechanical properties of the surrounding microenvironments. From an end-point perspective, the success of a microfluidic OoAC relies mainly on the type of biomaterial and the fabrication strategy employed. Certain biomaterials, such as PDMS (polydimethylsiloxane), are preferred over others due to their ease of fabrication and proven success in modelling complex organ systems. However, the inherent nature of human microtissues to respond differently to surrounding stimulations has led to the combination of biomaterials ranging from simple PDMS chips to 3D-printed polymers coated with natural and synthetic materials, including hydrogels. In addition, recent advances in 3D printing and bioprinting techniques have led to the powerful combination of utilizing these materials to develop microfluidic OoAC devices. In this narrative review, we evaluate the different materials used to fabricate microfluidic OoAC devices while outlining their pros and cons in different organ systems. A note on combining the advances made in additive manufacturing (AM) techniques for the microfabrication of these complex systems is also discussed. Full article
(This article belongs to the Special Issue Materials for Bioengineering and Biotechnology)
Show Figures

Figure 1

34 pages, 826 KiB  
Review
Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer’s Disease?
by Zoe B. Mills 1, Richard L. M. Faull 1 and Andrea Kwakowsky 1,2,*
1 Centre for Brain Research, Department of Anatomy and Medical Imaging, Faculty of Medical and Health Science, University of Auckland, Auckland 1023, New Zealand
2 Pharmacology and Therapeutics, School of Medicine, Galway Neuroscience Centre, Ollscoil na Gaillimhe—University of Galway, H91 W5P7 Galway, Ireland
Int. J. Mol. Sci. 2023, 24(4), 3205; https://doi.org/10.3390/ijms24043205 - 6 Feb 2023
Cited by 41 | Viewed by 9742
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that accounts for more than half of all dementia cases in the elderly. Interestingly, the clinical manifestations of AD disproportionately affect women, comprising two thirds of all AD cases. Although the underlying mechanisms for these [...] Read more.
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that accounts for more than half of all dementia cases in the elderly. Interestingly, the clinical manifestations of AD disproportionately affect women, comprising two thirds of all AD cases. Although the underlying mechanisms for these sex differences are not fully elucidated, evidence suggests a link between menopause and a higher risk of developing AD, highlighting the critical role of decreased estrogen levels in AD pathogenesis. The focus of this review is to evaluate clinical and observational studies in women, which have investigated the impact of estrogens on cognition or attempted to answer the prevailing question regarding the use of hormone replacement therapy (HRT) as a preventive or therapeutic option for AD. The articles were retrieved through a systematic review of the databases: OVID, SCOPUS, and PubMed (keywords “memory”, “dementia,” “cognition,” “Alzheimer’s disease”, “estrogen”, “estradiol”, “hormone therapy” and “hormone replacement therapy” and by searching reference sections from identified studies and review articles). This review presents the relevant literature available on the topic and discusses the mechanisms, effects, and hypotheses that contribute to the conflicting findings of HRT in the prevention and treatment of age-related cognitive deficits and AD. The literature suggests that estrogens have a clear role in modulating dementia risk, with reliable evidence showing that HRT can have both a beneficial and a deleterious effect. Importantly, recommendation for the use of HRT should consider the age of initiation and baseline characteristics, such as genotype and cardiovascular health, as well as the dosage, formulation, and duration of treatment until the risk factors that modulate the effects of HRT can be more thoroughly investigated or progress in the development of alternative treatments can be made. Full article
(This article belongs to the Special Issue Neurotransmitters and Hormones in Neurological Disorders)
Show Figures

Figure 1

24 pages, 9704 KiB  
Review
Probiotics as a Tool for Regulating Molecular Mechanisms in Depression: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by Michalina Sikorska 1, Anna Z. Antosik-Wójcińska 2 and Monika Dominiak 3,*
1 Medical Center of Postgraduate Education, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
2 Department of Psychiatry, Faculty of Medicine, Collegium Medicum, Cardinal Wyszynski University in Warsaw, Woycickiego 1/3, 01-938 Warsaw, Poland
3 Department of Pharmacology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warsaw, Poland
Int. J. Mol. Sci. 2023, 24(4), 3081; https://doi.org/10.3390/ijms24043081 - 4 Feb 2023
Cited by 24 | Viewed by 9737
Abstract
Depression is one of the main mental disorders. Pharmacological treatment of depression is often associated with delayed effects or insufficient efficacy. Consequently, there is a need to discover new therapeutic methods to cope with depression faster and more effectively. Several lines of evidence [...] Read more.
Depression is one of the main mental disorders. Pharmacological treatment of depression is often associated with delayed effects or insufficient efficacy. Consequently, there is a need to discover new therapeutic methods to cope with depression faster and more effectively. Several lines of evidence indicate that the use of probiotic therapy reduces depressive symptoms. Nonetheless, the exact mechanisms linking the gut microbiota and the central nervous system, as well as the potential mechanisms of action for probiotics, are still not entirely clarified. The aim of this review was to systematically summarize the available knowledge according to PRISMA guidelines on the molecular mechanisms linking probiotics and healthy populations with subclinical depression or anxiety symptoms, as well as depressed patients with or without comorbid somatic illnesses. The standardized mean difference (SMD) with 95% confidence intervals (CI) was calculated. Twenty records were included. It has been found that probiotic administration is linked to a significant increase in BDNF levels during probiotic treatment compared to the placebo (SMD = 0.37, 95% CI [0.07, 0.68], p = 0.02) when considering the resolution of depressive symptoms in depressed patients with or without comorbid somatic illnesses. CRP levels were significantly lower (SMD = −0.47, 95% CI [0.75, −0.19], p = 0.001), and nitric oxide levels were significantly higher (SMD = 0.97, 95% CI [0.58, 1.36], p < 0.0001) in probiotic-treated patients compared to the placebo, however, only among depressed patients with somatic co-morbidities. There were no significant differences in IL-1β, IL-6, IL-10, TNF-α, and cortisol levels after probiotic administration between the intervention and control groups (all p > 0.05). Firm conclusions on the effectiveness of probiotics and their possible association with inflammatory markers in the healthy population (only with subclinical depressive or anxiety symptoms) cannot be drawn. The advent of clinical trials examining the long-term administration of probiotics could evaluate the long-term effectiveness of probiotics in treating depression and preventing its recurrence. Full article
(This article belongs to the Special Issue Depression: Molecular Pathology and Modern Therapy)
Show Figures

Figure 1

37 pages, 1622 KiB  
Review
Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders
by Hiroshi Kitamura
Laboratory of Comparative Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan
Int. J. Mol. Sci. 2023, 24(4), 3219; https://doi.org/10.3390/ijms24043219 - 6 Feb 2023
Cited by 73 | Viewed by 9688
Abstract
Ubiquitination and deubiquitination are reversible processes that modify the characteristics of target proteins, including stability, intracellular localization, and enzymatic activity. Ubiquitin-specific proteases (USPs) constitute the largest deubiquitinating enzyme family. To date, accumulating evidence indicates that several USPs positively and negatively affect metabolic diseases. [...] Read more.
Ubiquitination and deubiquitination are reversible processes that modify the characteristics of target proteins, including stability, intracellular localization, and enzymatic activity. Ubiquitin-specific proteases (USPs) constitute the largest deubiquitinating enzyme family. To date, accumulating evidence indicates that several USPs positively and negatively affect metabolic diseases. USP22 in pancreatic β-cells, USP2 in adipose tissue macrophages, USP9X, 20, and 33 in myocytes, USP4, 7, 10, and 18 in hepatocytes, and USP2 in hypothalamus improve hyperglycemia, whereas USP19 in adipocytes, USP21 in myocytes, and USP2, 14, and 20 in hepatocytes promote hyperglycemia. In contrast, USP1, 5, 9X, 14, 15, 22, 36, and 48 modulate the progression of diabetic nephropathy, neuropathy, and/or retinopathy. USP4, 10, and 18 in hepatocytes ameliorates non-alcoholic fatty liver disease (NAFLD), while hepatic USP2, 11, 14, 19, and 20 exacerbate it. The roles of USP7 and 22 in hepatic disorders are controversial. USP9X, 14, 17, and 20 in vascular cells are postulated to be determinants of atherosclerosis. Moreover, mutations in the Usp8 and Usp48 loci in pituitary tumors cause Cushing syndrome. This review summarizes the current knowledge about the modulatory roles of USPs in energy metabolic disorders. Full article
(This article belongs to the Special Issue Regulation of Ubiquitin Family Signaling in Disease)
Show Figures

Graphical abstract

31 pages, 2302 KiB  
Review
Gelatin as It Is: History and Modernity
by Oleg V. Mikhailov
Department of Analytical Chemistry, Certification and Quality Management, Kazan National Research Technological University, K. Marx Street 68, 420015 Kazan, Russia
Int. J. Mol. Sci. 2023, 24(4), 3583; https://doi.org/10.3390/ijms24043583 - 10 Feb 2023
Cited by 74 | Viewed by 9647
Abstract
The data concerning the synthesis and physicochemical characteristics of one of the practically important proteins—gelatin, as well as the possibilities of its practical application, are systematized and discussed. When considering the latter, emphasis is placed on the use of gelatin in those areas [...] Read more.
The data concerning the synthesis and physicochemical characteristics of one of the practically important proteins—gelatin, as well as the possibilities of its practical application, are systematized and discussed. When considering the latter, emphasis is placed on the use of gelatin in those areas of science and technology that are associated with the specifics of the spatial/molecular structure of this high-molecular compound, namely, as a binder for the silver halide photographic process, immobilized matrix systems with a nano-level organization of an immobilized substance, matrices for creating pharmaceutical/dosage forms and protein-based nanosystems. It was concluded that the use of this protein is promising in the future. Full article
(This article belongs to the Special Issue Protein Biosynthesis and Drug Design & Delivery Processes)
Show Figures

Figure 1

18 pages, 928 KiB  
Review
Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs
by Teresa Iantomasi 1,*, Cecilia Romagnoli 1, Gaia Palmini 1, Simone Donati 1, Irene Falsetti 1, Francesca Miglietta 1, Cinzia Aurilia 1, Francesca Marini 2, Francesca Giusti 1 and Maria Luisa Brandi 2
1 Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
2 F.I.R.M.O. Italian Foundation for Research on Bone Disease, Via San Gallo 123, 50129 Florence, Italy
Int. J. Mol. Sci. 2023, 24(4), 3772; https://doi.org/10.3390/ijms24043772 - 14 Feb 2023
Cited by 184 | Viewed by 9620
Abstract
Osteoporosis is characterized by the alteration of bone homeostasis due to an imbalance between osteoclastic bone resorption and osteoblastic bone formation. Estrogen deficiency causes bone loss and postmenopausal osteoporosis, the pathogenesis of which also involves oxidative stress, inflammatory processes, and the dysregulation of [...] Read more.
Osteoporosis is characterized by the alteration of bone homeostasis due to an imbalance between osteoclastic bone resorption and osteoblastic bone formation. Estrogen deficiency causes bone loss and postmenopausal osteoporosis, the pathogenesis of which also involves oxidative stress, inflammatory processes, and the dysregulation of the expression of microRNAs (miRNAs) that control gene expression at post-transcriptional levels. Oxidative stress, due to an increase in reactive oxygen species (ROS), proinflammatory mediators and altered levels of miRNAs enhance osteoclastogenesis and reduce osteoblastogenesis through mechanisms involving the activation of MAPK and transcription factors. The present review summarizes the principal molecular mechanisms involved in the role of ROS and proinflammatory cytokines on osteoporosis. Moreover, it highlights the interplay among altered miRNA levels, oxidative stress, and an inflammatory state. In fact, ROS, by activating the transcriptional factors, can affect miRNA expression, and miRNAs can regulate ROS production and inflammatory processes. Therefore, the present review should help in identifying targets for the development of new therapeutic approaches to osteoporotic treatment and improve the quality of life of patients. Full article
Show Figures

Figure 1

21 pages, 927 KiB  
Review
Current Status of Cell-Based Therapies for Vitiligo
by Anna Domaszewska-Szostek 1, Agnieszka Polak 2, Monika Słupecka-Ziemilska 1,*, Marta Krzyżanowska 3 and Monika Puzianowska-Kuźnicka 1,4
1 Department of Human Epigenetics, Mossakowski Medical Research Institute, PAS, 02-106 Warsaw, Poland
2 Faculty of Biology, University of Cambridge, Cambridge CD2 1TN, UK
3 Division of Ophthalmology and Optometry, Department of Ophthalmology, Collegium Medicum, Nicolaus Copernicus University in Toruń, 85-168 Bydgoszcz, Poland
4 Department of Geriatrics and Gerontology, Medical Centre of Postgraduate Education, 01-813 Warsaw, Poland
Int. J. Mol. Sci. 2023, 24(4), 3357; https://doi.org/10.3390/ijms24043357 - 8 Feb 2023
Cited by 10 | Viewed by 9547
Abstract
Vitiligo is a chronic pigmentary disease with complex etiology, the signs of which are caused by the destruction of melanocytes in the epidermis, leading to the lack of melanin pigment responsible for skin coloration. The treatment of vitiligo, which aims at repigmentation, depends [...] Read more.
Vitiligo is a chronic pigmentary disease with complex etiology, the signs of which are caused by the destruction of melanocytes in the epidermis, leading to the lack of melanin pigment responsible for skin coloration. The treatment of vitiligo, which aims at repigmentation, depends both on the clinical characteristics of the disease as well as on molecular markers that may predict the response to treatment. The aim of this review is to provide an overview of the clinical evidence for vitiligo cell-based therapies taking into account the required procedures and equipment necessary to carry them out as well as their effectiveness in repigmentation, assessed using the percentage of repigmentation of the treated area. This review was conducted by assessing 55 primary clinical studies published in PubMed and ClinicalTrails.gov between 2000 and 2022. This review concludes that the extent of repigmentation, regardless of the treatment method, is highest in stable localized vitiligo patients. Moreover, therapies that combine more than one cell type, such as melanocytes and keratinocytes, or more than one method of treatment, such as the addition of NV-UVB to another treatment, increase the chances of >90% repigmentation. Lastly, this review concludes that various body parts respond differently to all treatments. Full article
(This article belongs to the Special Issue Sustainable Approaches in Skin Conditions)
Show Figures

Figure 1

12 pages, 566 KiB  
Review
The Complex Interplay between Nevi and Melanoma: Risk Factors and Precursors
by Rony Shreberk-Hassidim 1,2,3, Stephen M. Ostrowski 1,2 and David E. Fisher 1,2,*
1 Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
2 Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA
3 Department of Dermatology, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112001, Israel
Int. J. Mol. Sci. 2023, 24(4), 3541; https://doi.org/10.3390/ijms24043541 - 10 Feb 2023
Cited by 21 | Viewed by 9359
Abstract
One effort to combat the rising incidence of malignant melanoma is focused on early detection by the clinical and dermoscopic screening of melanocytic nevi. However, the interaction between nevi, which are congenital or acquired benign melanocytic proliferations, and melanoma is still enigmatic. On [...] Read more.
One effort to combat the rising incidence of malignant melanoma is focused on early detection by the clinical and dermoscopic screening of melanocytic nevi. However, the interaction between nevi, which are congenital or acquired benign melanocytic proliferations, and melanoma is still enigmatic. On the one hand, the majority of melanomas are thought to form de novo, as only a third of primary melanomas are associated with a histologically identifiable nevus precursor. On the other hand, an increased number of melanocytic nevi is a strong risk factor for developing melanoma, including melanomas that do not derive from nevi. The formation of nevi is modulated by diverse factors, including pigmentation, genetic risk factors, and environmental sun exposure. While the molecular alterations that occur during the progression of a nevus to melanoma have been well characterized, many unanswered questions remain surrounding the process of nevus to melanoma evolution. In this review, we discuss clinical, histological, molecular, and genetic factors that influence nevus formation and progression to melanoma. Full article
(This article belongs to the Special Issue Skin Cancer: From Pathophysiology to Novel Therapy)
Show Figures

Figure 1

12 pages, 1941 KiB  
Review
Adverse Human Health Effects of Chromium by Exposure Route: A Comprehensive Review Based on Toxicogenomic Approach
by Dong Yeop Shin 1, Sang Min Lee 2, Yujin Jang 1, Jun Lee 1, Cheol Min Lee 3, Eun-Min Cho 3,* and Young Rok Seo 1,*
1 Institute of Environmental Medicine for Green Chemistry, Department of Life Science, Dongguk University Biomedi Campus, 32 Dongguk-ro, Ilsandong-gu, Goyang-si 10326, Republic of Korea
2 Insilicogen Inc., Suwon 441813, Republic of Korea
3 Department of Nano, Chemical & Biological Engineering, College of Natural Science and Engineering, Seokyeong University, Seoul 02173, Republic of Korea
Int. J. Mol. Sci. 2023, 24(4), 3410; https://doi.org/10.3390/ijms24043410 - 8 Feb 2023
Cited by 70 | Viewed by 9247
Abstract
Heavy metals are defined as metals with relatively high density and atomic weight, and their various applications have raised serious concerns about the environmental impacts and potential human health effects. Chromium is an important heavy metal that is involved in biological metabolism, but [...] Read more.
Heavy metals are defined as metals with relatively high density and atomic weight, and their various applications have raised serious concerns about the environmental impacts and potential human health effects. Chromium is an important heavy metal that is involved in biological metabolism, but Cr exposure can induce a severe impact on occupational workers or public health. In this study, we explore the toxic effects of Cr exposure through three exposure routes: dermal contact, inhalation, and ingestion. We propose the underlying toxicity mechanisms of Cr exposure based on transcriptomic data and various bioinformatic tools. Our study provides a comprehensive understanding of the toxicity mechanisms of different Cr exposure routes by diverse bioinformatics analyses. Full article
(This article belongs to the Special Issue Heavy Metal Toxicity in Humans 2.0)
Show Figures

Figure 1